Uptake of Recommendations for Posttreatment Cancer-Related Fatigue Among Breast Cancer Survivors

Authors:
Antonio Di Meglio INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif;

Search for other papers by Antonio Di Meglio in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Cecile Charles Département de Soins de Support, Gustave Roussy, Villejuif;
Laboratoire de Psychopathologie et Processus de Santé, Université Paris Descartes-Sorbonne Paris Cité, Boulogne-Billancourt;

Search for other papers by Cecile Charles in
Current site
Google Scholar
PubMed
Close
 PhD
,
Elise Martin INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif;

Search for other papers by Elise Martin in
Current site
Google Scholar
PubMed
Close
 PhD
,
Julie Havas INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif;

Search for other papers by Julie Havas in
Current site
Google Scholar
PubMed
Close
 MSc
,
Arnauld Gbenou INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif;

Search for other papers by Arnauld Gbenou in
Current site
Google Scholar
PubMed
Close
 MSc
,
Jean-Daniel Flaysakier INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif;

Search for other papers by Jean-Daniel Flaysakier in
Current site
Google Scholar
PubMed
Close
 MD
,
Anne-Laure Martin UNICANCER, Paris;

Search for other papers by Anne-Laure Martin in
Current site
Google Scholar
PubMed
Close
 PhD
,
Sibille Everhard UNICANCER, Paris;

Search for other papers by Sibille Everhard in
Current site
Google Scholar
PubMed
Close
 PhD
,
Enora Laas Medical Oncology, Institut Curie, Paris;

Search for other papers by Enora Laas in
Current site
Google Scholar
PubMed
Close
 MD
,
Nicolas Chopin Medical Oncology, Centre Léon Berard, Lyon;

Search for other papers by Nicolas Chopin in
Current site
Google Scholar
PubMed
Close
 MD
,
Laurence Vanlemmens Medical Oncology, Centre Oscar Lambret, Lille;

Search for other papers by Laurence Vanlemmens in
Current site
Google Scholar
PubMed
Close
 MD
,
Christelle Jouannaud Medical Oncology, Institut Jean Godinot, Reims;

Search for other papers by Christelle Jouannaud in
Current site
Google Scholar
PubMed
Close
 MD
,
Christelle Levy Medical Oncology, Centre François Baclesse, Caen;

Search for other papers by Christelle Levy in
Current site
Google Scholar
PubMed
Close
 MD
,
Olivier Rigal Medical Oncology, Centre Henri Becquerel, Rouen;

Search for other papers by Olivier Rigal in
Current site
Google Scholar
PubMed
Close
 MD
,
Marion Fournier Medical Oncology, Institut Bergonié, Bordeaux;

Search for other papers by Marion Fournier in
Current site
Google Scholar
PubMed
Close
 MD
,
Patrick Soulie Medical Oncology, Institut de Cancérologie de L'ouest-Paul Papin, Angers;

Search for other papers by Patrick Soulie in
Current site
Google Scholar
PubMed
Close
 MD
,
Florian Scotte Département de Soins de Support, Gustave Roussy, Villejuif;

Search for other papers by Florian Scotte in
Current site
Google Scholar
PubMed
Close
 MD
,
Barbara Pistilli INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif;

Search for other papers by Barbara Pistilli in
Current site
Google Scholar
PubMed
Close
 MD
,
Agnes Dumas Universite de Paris, ECEVE UMR 1123 INSERM, Paris; and

Search for other papers by Agnes Dumas in
Current site
Google Scholar
PubMed
Close
 PhD
,
Gwenn Menvielle Institut Pierre Louis d’Épidémiologie et de Santé Publique, Sorbonne Université, INSERM, Paris, France.

Search for other papers by Gwenn Menvielle in
Current site
Google Scholar
PubMed
Close
 PhD
,
Fabrice André INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif;

Search for other papers by Fabrice André in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Stefan Michiels INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif;

Search for other papers by Stefan Michiels in
Current site
Google Scholar
PubMed
Close
 PhD
,
Sarah Dauchy Département de Soins de Support, Gustave Roussy, Villejuif;

Search for other papers by Sarah Dauchy in
Current site
Google Scholar
PubMed
Close
 MD
, and
Ines Vaz-Luis INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif;

Search for other papers by Ines Vaz-Luis in
Current site
Google Scholar
PubMed
Close
 MD, PhD
Restricted access

Background: Physical activity (PA) and psychosocial interventions are recommended management strategies for cancer-related fatigue (CRF). Randomized trials support the use of mind–body techniques, whereas no data show benefit for homeopathy or naturopathy. Methods: We used data from CANTO (ClinicalTrials.gov identifier: NCT01993498), a multicenter, prospective study of stage I–III breast cancer (BC). CRF, evaluated after primary treatment completion using the EORTC QLQ-C30 (global CRF) and QLQ-FA12 (physical, emotional, and cognitive dimensions), served as the independent variable (severe [score of ≥40/100] vs nonsevere). Outcomes of interest were adherence to PA recommendations (≥10 metabolic equivalent of task [MET] h/week [GPAQ-16]) and participation in consultations with a psychologist, psychiatrist, acupuncturist, or other complementary and alternative medicine (CAM) practitioner (homeopath and/or naturopath) after CRF assessment. Multivariable logistic regression examined associations between CRF and outcomes, adjusting for sociodemographic, psychologic, tumor, and treatment characteristics. Results: Among 7,902 women diagnosed from 2012 through 2017, 36.4% reported severe global CRF, and 35.8%, 22.6%, and 14.1% reported severe physical, emotional, and cognitive CRF, respectively. Patients reporting severe global CRF were less likely to adhere to PA recommendations (60.4% vs 66.7%; adjusted odds ratio [aOR], 0.82; 95% CI, 0.71–0.94; P=.004), and slightly more likely to see a psychologist (13.8% vs 7.5%; aOR, 1.29; 95% CI, 1.05–1.58; P=.014), psychiatrist (10.4% vs 5.0%; aOR, 1.39; 95% CI, 1.10–1.76; P=.0064), acupuncturist (9.8% vs 6.5%; aOR, 1.46; 95% CI, 1.17–1.82; P=.0008), or CAM practitioner (12.5% vs 8.2%; aOR, 1.49; 95% CI, 1.23–1.82; P<.0001). There were differences in recommendation uptake by CRF dimension, including that severe physical CRF was associated with lower adherence to PA (aOR, 0.74; 95% CI, 0.63–0.86; P=.0001) and severe emotional CRF was associated with higher likelihood of psychologic consultations (aOR, 1.37; 95% CI, 1.06–1.79; P=.017). Conclusions: Uptake of recommendations to improve CRF, including adequate PA and use of psychosocial services, seemed suboptimal among patients with early-stage BC, whereas there was a nonnegligible interest in homeopathy and naturopathy. Findings of this large study indicate the need to implement recommendations for managing CRF in clinical practice.

Submitted August 20, 2020; final revision received November 5, 2020; accepted for publication April 26, 2021. Published online February 7, 2022.

Previous presentation: Results of this study were partly presented at the ESMO Breast Cancer Virtual Meeting; May 23–24, 2020. Proffered Paper session 1. Ann Oncol 2020;31(Suppl 2):S83–87.

Author contributions: Study concept: Di Meglio, Charles, E. Martin, Flaysakier, A.L. Martin, Everhard, Laas, Chopin, Vanlemmens, Jouannaud, Levy, Rigal, Fournier, Soulie, Scotte, Pistilli, Dumas, Menvielle, André, Michiels, Dauchy, Vaz-Luis. Data curation: Di Meglio, Havas, Gbenou, Vaz-Luis. Formal analysis: Di Meglio, Havas, Gbenou, Vaz-Luis. Funding acquisition: Di Meglio, Vaz-Luis. Investigation: Di Meglio, Charles, E. Martin, Flaysakier, A.L. Martin, Everhard, Laas, Chopin, Vanlemmens, Jouannaud, Levy, Rigal, Fournier, Soulie, Scotte, Pistilli, Dumas, Menvielle, André, Michiels, Dauchy, Vaz-Luis. Methodology: All authors. Project administration: Di Meglio, A.L. Martin, Everhard, Vaz-Luis. Resources: Di Meglio, A.L. Martin, Everhard, Vaz-Luis. Software: Di Meglio, Vaz-Luis. Supervision: Di Meglio, Vaz-Luis. Validation: Di Meglio, Charles, E. Martin, Flaysakier, A.L. Martin, Everhard, Laas, Chopin, Vanlemmens, Jouannaud, Levy, Rigal, Fournier, Soulie, Scotte, Pistilli, Dumas, Menvielle, André, Michiels, Dauchy, Vaz-Luis. Visualization: Di Meglio, Vaz-Luis. Writing – original draft: Di Meglio, Vaz-Luis. Writing – review and editing: Di Meglio, Vaz-Luis.

Disclosures: Dr. Michiels has disclosed serving on a data safety monitoring board for Sensorion, Biophytis, Servier, and Yuhan, and serving as a consultant for IDDI, Amaris, and Roche. Dr. Vaz-Luis has disclosed receiving honoraria for education purposes (institutional) from AstraZeneca and Pfizer/Edimark. The remaining authors have disclosed that they have not received any financial consideration from any person or organization to support the preparation, analysis, results, or discussion of this article.

Funding: This work was supported by funding from a Career Pathway Grant in Symptom Management from Conquer Cancer, ASCO, and Rising Tide Foundation for Clinical Cancer Research (A. Di Meglio), Susan G. Komen (CCR17483507 to I. Vaz-Luis), Odyssea (I. Vaz-Luis), the French Foundation for Cancer Research (I. Vaz-Luis), Fondation Gustave Roussy (I. Vaz-Luis), and Breast Cancer Research Foundation. The CANTO study is supported by the French Government under the “Investment for the Future” program, managed by the National Research Agency (ANR), grant N. ANR-10-COHO-0004.

Correspondence: Ines Vaz-Luis, MD, PhD, Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. Email: ines-maria.vaz-duarte-luis@gustaveroussy.fr

Supplementary Materials

    • Supplemental Materials (PDF 509 KB)
  • Collapse
  • Expand
  • 1.

    Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394424.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:734.

  • 3.

    Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008;9:730756.

  • 4.

    Stan D, Loprinzi CL, Ruddy KJ. Breast cancer survivorship issues. Hematol Oncol Clin North Am 2013;27:805827, ix.

  • 5.

    Hofman M, Ryan JL, Figueroa-Moseley CD, et al. Cancer-related fatigue: the scale of the problem. Oncologist 2007;12(Suppl 1): 410.

  • 6.

    Bower JE, Ganz PA, Desmond KA, et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer 2006;106: 751758.

  • 7.

    Bower JE, Ganz PA, Desmond KA, et al. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 2000;18:743753.

  • 8.

    Abrahams HJG, Gielissen MFM, Schmits IC, et al. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors. Ann Oncol 2016;27:965974.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Poulson MJ. Not just tired. J Clin Oncol 2001;19:41804181.

  • 10.

    Andrykowski MA, Donovan KA, Laronga C, et al. Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Cancer 2010;116:57405748.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Cella D, Lai JS, Chang CH, et al. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 2002;94:528538.

  • 12.

    Bower JE. Cancer-related fatigue—mechanisms, risk factors, and treatments. Nat Rev Clin Oncol 2014;11:597609.

  • 13.

    Cella D, Davis K, Breitbart W, et al. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 2001;19:33853391.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Minton O, Stone P. A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol 2009;20:1725.

  • 15.

    Curt GA, Breitbart W, Cella D, et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 2000;5:353360.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Broeckel JA, Jacobsen PB, Horton J, et al. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 1998;16:16891696.

  • 17.

    Collado-Hidalgo A, Bower JE, Ganz PA, et al. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 2006;12:27592766.

  • 18.

    Bower JE, Ganz PA, Irwin MR, et al. Fatigue and gene expression in human leukocytes: increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain Behav Immun 2011;25:147150.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19.

    Orre IJ, Reinertsen KV, Aukrust P, et al. Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors. J Psychosom Res 2011;71:136141.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20.

    Bower JE, Ganz PA, Tao ML, et al. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res 2009;15:55345540.

  • 21.

    Geinitz H, Zimmermann FB, Stoll P, et al. Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. Int J Radiat Oncol Biol Phys 2001;51:691698.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22.

    Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2012;11:CD006145.

  • 23.

    Patel AV, Friedenreich CM, Moore SC, et al. American College of Sports Medicine Roundtable Report on Physical Activity, Sedentary Behavior, and Cancer Prevention and Control. Med Sci Sports Exerc 2019;51:23912402.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24.

    Brown JC, Huedo-Medina TB, Pescatello LS, et al. Efficacy of exercise interventions in modulating cancer-related fatigue among adult cancer survivors: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2011;20:123133.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25.

    Speck RM, Courneya KS, Mâsse LC, et al. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 2010;4:87100.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26.

    Bower JE, Bak K, Berger A, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology clinical practice guideline adaptation. J Clin Oncol 2014;32:18401850.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27.

    Bouillet T, Bigard X, Brami C, et al. Role of physical activity and sport in oncology: scientific commission of the National Federation Sport and Cancer CAMI. Crit Rev Oncol Hematol 2015;94:7486.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28.

    Sebri V, Savioni L, Triberti S, et al. How to train your health: sports as a resource to improve cognitive abilities in cancer patients. Front Psychol 2019;10:2096.

  • 29.

    Pierce S, Gould D, Camiré M. Definition and model of life skills transfer. Int Rev Sport Exerc Psychol 2017;10:186211.

  • 30.

    Sebri V, Savioni L, Triberti S, et al. Do you transfer your skills? From sports to health management in cancer patients. Front Psychol 2020; 11:546.

  • 31.

    Duijts SFA, Faber MM, Oldenburg HSA, et al. Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors—a meta-analysis. Psychooncology 2011;20:115126.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32.

    Mind and body practices. National Center for Complementary and Integrative Health website. Accessed August 2, 2021. Available at: https://www.nccih.nih.gov/health/mind-and-body-practices

    • PubMed
    • Export Citation
  • 33.

    Berger AM, Mooney K, Banerjee C, et al. NCCN Clinical Practice Guidelines in Oncology: Cancer-Related Fatigue. Version 1.2021. Accessed December 12, 2020. To view the most recent version, visit NCCN.org

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34.

    Greenlee H, DuPont-Reyes MJ, Balneaves LG, et al. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin 2017;67:194232.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35.

    Towler P, Molassiotis A, Brearley SG. What is the evidence for the use of acupuncture as an intervention for symptom management in cancer supportive and palliative care: an integrative overview of reviews. Support Care Cancer 2013;21:29132923.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36.

    Posadzki P, Moon TW, Choi TY, et al. Acupuncture for cancer-related fatigue: a systematic review of randomized clinical trials. Support Care Cancer 2013;21:20672073.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37.

    Lau CHY, Wu X, Chung VCH, et al. Acupuncture and related therapies for symptom management in palliative cancer care: systematic review and meta-analysis. Medicine (Baltimore) 2016;95:e2901.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38.

    Vickers AJ, Straus DJ, Fearon B, et al. Acupuncture for postchemotherapy fatigue: a phase II study. J Clin Oncol 2004;22:17311735.

  • 39.

    Molassiotis A, Sylt P, Diggins H. The management of cancer-related fatigue after chemotherapy with acupuncture and acupressure: a randomised controlled trial. Complement Ther Med 2007;15:228237.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40.

    Lyman GH, Bohlke K, Cohen L. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline summary. J Oncol Pract 2018;14:495499.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41.

    Lyman GH, Greenlee H, Bohlke K, et al. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol 2018;36:26472655.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 42.

    Vaz-Luis I, Cottu P, Mesleard C, et al. UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO). ESMO Open 2019;4:e000562.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43.

    World Health Organization. Global Physical Activity Questionnaire Analysis Guide. Accessed August 2, 2021. Available at: https://www.who.int/ncds/surveillance/steps/resources/GPAQ_Analysis_Guide.pdf

    • PubMed
    • Export Citation
  • 44.

    Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365376.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 45.

    Weis J, Tomaszewski KA, Hammerlid E, et al. International psychometric validation of an EORTC quality of life module measuring cancer related fatigue (EORTC QLQ-FA12). J Natl Cancer Inst 2017;109:djw273.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46.

    Sprangers MA, Groenvold M, Arraras JI, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 1996;14:27562768.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 47.

    Fayers P, Aaronson NK, Bjordal K, et al. EORTC QLQ-C30 Scoring Manual. Brussels, Belgium: European Organisation for Research and Treatment of Cancer; 2001.

  • 48.

    Questionnaires. EORTC Quality of Life website. Accessed March 3, 2020. Available at: https://qol.eortc.org/questionnaires/

  • 49.

    Giesinger JM, Loth FLC, Aaronson NK, et al. Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research. J Clin Epidemiol 2020;118:18.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 50.

    Puetz TW, Herring MP. Differential effects of exercise on cancer-related fatigue during and following treatment: a meta-analysis. Am J Prev Med 2012;43:e124.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 51.

    Gielissen MFM, Verhagen CAHHVM, Bleijenberg G. Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up. Br J Cancer 2007;97:612618.

  • 52.

    Yun YH, Lee KS, Kim YW, et al. Web-based tailored education program for disease-free cancer survivors with cancer-related fatigue: a randomized controlled trial. J Clin Oncol 2012;30:12961303.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 53.

    Brown LF, Kroenke K. Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics 2009;50:440447.

  • 54.

    Kim Y, Hickok JT, Morrow G. Fatigue and depression in cancer patients undergoing chemotherapy: an emotion approach. J Pain Symptom Manage 2006;32:311321.

  • 55.

    Saïas T, du Roscoät E, Véron L, et al. Psychological distress in French college students: demographic, economic and social stressors: results from the 2010 National Health Barometer. BMC Public Health 2014;14:256.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 56.

    Husky MM, Guignard R, Beck F, et al. Risk behaviors, suicidal ideation and suicide attempts in a nationally representative French sample. J Affect Disord 2013;151:10591065.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 57.

    Leichsenring F, Steinert C. Is cognitive behavioral therapy the gold standard for psychotherapy? The need for plurality in treatment and research. JAMA 2017;318:13231324.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 58.

    Tirintica AR, Andjelkovic I, Sota O, et al. Factors that influence access to mental health services in South-Eastern Europe. Int J Ment Health Syst 2018;12:75.

  • 59.

    Charles C, Di Meglio I, A Arnedos, et al. QualFatigue study: which factors influence the use of specific interventions for breast cancer survivors with fatigue? A cross-sectional exploratory study. Support Care Cancer 2021;29:48274834.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 60.

    Martin E, Zingarello A, Di Meglio A, et al. A qualitative evaluation of the use of interventions to treat fatigue among cancer survivors: a healthcare provider's view. Eur J Cancer Care (Engl) 2021;30:e13370.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 61.

    Bhugra D, Sartorius N, Fiorillo A, et al. EPA guidance on how to improve the image of psychiatry and of the psychiatrist. Eur Psychiatry 2015;30:423430.

  • 62.

    Gaebel W, Zäske H, Zielasek J, et al. Stigmatization of psychiatrists and general practitioners: results of an international survey. Eur Arch Psychiatry Clin Neurosci 2015;265:189197.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 63.

    Addington J, Heinssen RK, Robinson DG, et al. Duration of untreated psychosis in community treatment settings in the United States. Psychiatr Serv 2015;66:753756.

  • 64.

    Callus E, Pravettoni G. The role of clinical psychology and peer to peer support in the management of chronic medical conditions—a practical example with adults with congenital heart disease. Front Psychol 2018;9:731.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 65.

    Kazantzaki E, Kondylakis H, Koumakis L, et al. Psycho-emotional tools for better treatment adherence and therapeutic outcomes for cancer patients. Stud Health Technol Inform 2016;224:129134.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 66.

    Lapidari P, Djehal N, Havas J, et al. Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatigue. Breast Cancer Res Treat 2021;190:517529.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 67.

    McCambridge J, Witton J, Elbourne DR. Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol 2014;67:267277.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 68.

    Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361370.

  • 69.

    Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 2002;52:6977.

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 2269 1102 313
PDF Downloads 577 250 33
EPUB Downloads 0 0 0